Cambrex announced the completion of its $38 million capacity expansion at its small molecule active pharmaceutical ingredient (API) manufacturing facility in High Point, North Carolina. This expansion doubles the facility's manufacturing capacity, with new state-of-the-art analytical and chemical development laborator…
HERMES PHARMA, the leading expert in user-friendly oral dosage forms, has announced it will invest €25 million to further bolster its manufacturing capabilities. The investment will arm the company with new equipment, increased production and storage capacity, and greater operational efficiency to meet the rapidly gro…
OBiO Technology, a prominent leader in the Cell and Gene Therapy (CGT) field and a Contract Development and Manufacturing Organization, proudly unveiled the official launch of its state-of-the-art GMP production facility, christened as OBiO Intelli-M. The launch of the new base in Shanghai will enhance OBiO's product…
Besins Healthcare, a global lead in Women's and Men's Reproductive Health, today unveiled its novel hormone production facility in Muel, situated near Zaragoza, Spain. This event represents a significant moment in European pharmaceutical history. Built in an astounding time frame since its foundation in mid-2022, thi…
Bharat Serums and Vaccines Limited (BSV) hosted the groundbreaking ceremony of its new manufacturing plant at Genome Valley in Hyderabad, Telangana, in the presence of K.T Rama Rao, Minister for Municipal Administration and Urban Development; Industries and Commerce; and Information Technology, Electronics and Communi…
WuXi Vaccines, a leading contract development and manufacturing organization (CDMO) focused on vaccine discovery, development, and manufacturing, has launched its first standalone vaccines CDMO site in Suzhou, China. The opening will add drug substance and drug product capacity, with end-to-end services for diversifi…
Biomerics, the leading vertically integrated medical device contract manufacturer in the interventional device market, announced the completion of a 100,000-square-foot expansion of their operations in Brooklyn Park, Minnesota, bringing the facility to a total size of 170,000 square feet. Driven by increased demand, t…
ST Pharm successfully marked the completion of its groundbreaking ceremony, signaling a significant step forward in expanding its oligonucleotide manufacturing capacity and capabilities. The current expansion is in response to the growing demand for oligonucleotide therapeutics, including ASO, siRNA, and CRISPR, and …
Wexford Science & Technology, announced that the National Institutes of Health has signed a lease at 850 PBC and will use the space to accommodate the Phoenix Epidemiology & Clinical Research Branch of the NIH's National Institute of Diabetes and Digestive and Kidney Diseases . This innovative basic, translat…
Astellas Pharma Inc announced its intention to submit a planning application to build a new state-of-the-art facility, at an approximate cost of €330 million in Tralee, Co. Kerry. This investment by Astellas in Ireland will expand our capacity and capabilities for aseptic drug products, reinforce stable production f…
Page 49 of 61